27th May 2025 Plain language summary: Five-year results of nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer
30th Jul 2024 Plain language summary: N-803 plus BCG for BCG-naïve or unresponsive non-muscle invasive bladder cancer